Clinical Trials Logo

Clinical Trial Summary

This is an international, multicenter, open-label, randomized controlled trial. All patients undergoing transfemoral TAVR at the participating centers will be eligible. All sites will initiate enrolment with 2 feasibility roll-in bivalirudin treated patients and thereafter patients will be randomly assigned to either standard dosing of bivalirudin or UFH as control. The 2 roll-in cases per site will constitute the feasibility cohort that will be followed and analyzed separately. Patients will undergo TAVR according to current standard of care practices at the treating centers. Use of antiplatelet agents pre, during, and post procedure, and possibly oral anticoagulants post procedure, will be according to the sites' standard practice. ALL available data will be collected in the eCRF prospectively


Clinical Trial Description

This study will be an international, multi-center, open-label, randomized controlled trial in patients undergoing TAVR. Following the conclusion of the roll-in phase of 2 patients per site, who will comprise the feasibility cohort of approximately 70 patients, 550 patients will be randomized to bivalirudin or UFH at approximately 35 centers. Informed consent will be obtained from patients meeting the inclusion criteria before the initiation of any study-specific procedures. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01651780
Study type Interventional
Source The Medicines Company
Contact
Status Completed
Phase Phase 3
Start date October 2012
Completion date August 2015

See also
  Status Clinical Trial Phase
Recruiting NCT04149600 - Identification of Genetic Causes of Calcific Aortic Valve Disease
Enrolling by invitation NCT04035356 - HAART Annuloplasty Device Valve Repair Registry
Unknown status NCT01201070 - Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery Phase 4
Active, not recruiting NCT04281771 - Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI N/A
Completed NCT03644784 - Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam.
Recruiting NCT02288871 - Pilot Trial: Comparison of Flow Patterns N/A
Completed NCT01171625 - Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX N/A
Terminated NCT00598598 - Echocardiographic Assessment of Cardiovascular Changes in Long Term Space Flight N/A
Recruiting NCT05295628 - Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR N/A
Recruiting NCT06034028 - J-Valve TF Early Feasibility Study N/A
Recruiting NCT06295068 - Evaluation of ARi With OpSens SavvyWire
Completed NCT05742789 - Effect of Anesthetics on Troponin I and С-reactive Protein Phase 1
Recruiting NCT05172973 - ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves N/A
Completed NCT00727181 - An Observational, Prospective Evaluation of the Trifecta™ Valve N/A
Active, not recruiting NCT04415047 - The JenaValve ALIGN-AR Pivotal Trial N/A
Not yet recruiting NCT02623907 - China Valve Registry Study-1 N/A
Completed NCT00475267 - Aortic Valve Replacement With Trifecta(TM) N/A
Completed NCT00478803 - Conservative Aortic Valve Surgery for Aortic Insufficiency and Aneurysms of the Aortic Root. CAVIAAR Phase 3
Completed NCT00001314 - Investigation of Heart Function in Patients With Heart Valve Defects N/A
Recruiting NCT04047082 - Online Videodensitometric Assessment of Aortic Regurgitation in the Cath-Lab